MTI-301 for the Treatment of Metastatic or Unresectable and Refractory Solid Cancers

NCT06911008 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
42
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Mayo Clinic

Collaborators